Literature DB >> 12853336

European Code Against Cancer and scientific justification: third version (2003).

P Boyle1, P Autier, H Bartelink, J Baselga, P Boffetta, J Burn, H J G Burns, L Christensen, L Denis, M Dicato, V Diehl, R Doll, S Franceschi, C R Gillis, N Gray, L Griciute, A Hackshaw, M Kasler, M Kogevinas, S Kvinnsland, C La Vecchia, F Levi, J G McVie, P Maisonneuve, J M Martin-Moreno, J Newton Bishop, F Oleari, P Perrin, M Quinn, M Richards, U Ringborg, C Scully, E Siracka, H Storm, M Tubiana, T Tursz, U Veronesi, N Wald, W Weber, D G Zaridze, W Zatonski, H zur Hausen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853336     DOI: 10.1093/annonc/mdg305

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  49 in total

1.  Physical Health and Dual Diagnosis.

Authors:  Debbie Robson; Sarah Keen; Pia Mauro
Journal:  Adv Dual Diagn       Date:  2008

2.  Could gastrointestinal disorders differ in two close but divergent social environments?

Authors:  Ewa Grodzinsky; Claes Hallert; Tomas Faresjö; Elisabet Bergfors; Ashild Olsen Faresjö
Journal:  Int J Health Geogr       Date:  2012-02-06       Impact factor: 3.918

3.  Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration.

Authors:  Konstantinos Kamposioras; Davide Mauri; Vassilis Golfinopoulos; Georgios Ferentinos; Georgios Zacharias; Apostolos Xilomenos; Nikolaos P Polyzos; Magdalini Bristianou; Dimitra Chasioti; Athanasios Milousis; Angeliki Vittoraki; Georgios Koukourakis; Ioanna Chatziioannou; Panagiotis Papadopoulos
Journal:  Int J Colorectal Dis       Date:  2006-08-29       Impact factor: 2.571

Review 4.  Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma.

Authors:  C Bueno Muiño; J Puente Vázquez; J Sastre Valera; J A García-Sáenz; M Martín; N García Miralles; A Sánchez-Pernaute; E Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

5.  Europe combating cancer: the European Union's commitment to cancer research in the 6th Framework Programme.

Authors:  Stefan Jungbluth; Olaf Kelm; Jan-Willem van de Loo; Elengo Manoussaki; Maria Vidal; Manuel Hallen; Octavi Quintana Trias
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

6.  Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk.

Authors:  Satoshi Abiko; Yuichi Shimizu; Shuichi Miyamoto; Marin Ishikawa; Kana Matsuda; Momoko Tsuda; Takeshi Mizushima; Keiko Yamamoto; Shoko Ono; Takahiko Kudo; Kota Ono; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-02-08       Impact factor: 7.527

7.  European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document.

Authors:  M Arbyn; A Anttila; J Jordan; G Ronco; U Schenck; N Segnan; H Wiener; A Herbert; L von Karsa
Journal:  Ann Oncol       Date:  2010-03       Impact factor: 32.976

8.  Knowledge and attitudes of primary health care physicians and nurses with regard to population screening for colorectal cancer in Balearic Islands and Barcelona.

Authors:  Maria Ramos; Magdalena Esteva; Jesús Almeda; Elena Cabeza; Diana Puente; Rosa Saladich; Albert Boada; Maria Llagostera
Journal:  BMC Cancer       Date:  2010-09-20       Impact factor: 4.430

9.  Trends in socioeconomic inequalities in cancer mortality in Barcelona: 1992-2003.

Authors:  Rosa Puigpinós; Carme Borrell; José Leopoldo Ferreira Antunes; Enric Azlor; M Isabel Pasarín; Gemma Serral; Mariona Pons-Vigués; Maica Rodríguez-Sanz; Esteve Fernández
Journal:  BMC Public Health       Date:  2009-01-23       Impact factor: 3.295

10.  Alcohol consumption and breast cancer risk.

Authors:  Peter Boyle; Paolo Boffetta
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.